Keryx Biopharmaceuticals (Keryx Biopharmaceuticals) Debt-to-Equity : -2.72 (As of Sep. 2018)

Keryx Biopharmaceuticals Debt-to-Equity Chart

Keryx Biopharmaceuticals Annual Data
	Trend	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
Debt-to-Equity		Get a 7-Day Free Trial					-	-	1.04	-15.07	-8.87

Keryx Biopharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Debt-to-Equity	Get a 7-Day Free Trial															13.95	-8.87	-3.96	-3.16	-2.72

Competitive Comparison of Keryx Biopharmaceuticals's Debt-to-Equity

For the Biotechnology subindustry, Keryx Biopharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keryx Biopharmaceuticals's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keryx Biopharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Keryx Biopharmaceuticals's Debt-to-Equity falls into.

Keryx Biopharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Keryx Biopharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Keryx Biopharmaceuticals's Debt to Equity Ratio for the quarter that ended in Sep. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Keryx Biopharmaceuticals  (NAS:KERX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Keryx Biopharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Keryx Biopharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Keryx Biopharmaceuticals (Keryx Biopharmaceuticals) Business Description